Saturday, March 26, 2022

< + > Pfizer Recalling 3 Blood Pressure Medication Types Due To Cancer Concerns, FDA Says

This time the culprit is a nitrosamine, N-nitroso-quinapril, being present in quantities above Acceptable Daily Intake (ADI) levels.

No comments:

Post a Comment

< + > Bonus Features – December 21, 2025 – 80% of health systems use GenAI in RCM, one in three patients use GenAI for health advice weekly, plus 32 more stories

Welcome to the weekly edition of Healthcare IT Today Bonus Features . This article will be a weekly roundup of interesting stories, product ...